Hong Kong May Lower BioNTech Vaccine Age To 12
"); jQuery("#212 h3").html("
"); });
2021-06-02 HKT 00:38
Share this story
The Department of Health on Tuesday said it had received an application from Fosun Pharma on Saturday to lower the minimum age for the Comirnaty vaccine to 12, along with phase three clinical trial data.
It said the information had been passed on to the advisory panel on Covid-19 vaccines and that the secretary for food and health would consider any suggestions.
The department said it expected a decision could be reached quickly.
The minimum age for the Comirnaty vaccine, provided by BioNTech and its Greater China partner Fosun Pharma, is 16 in the SAR.
The minimum age for the other vaccine used in Hong Kong, which is made by Sinovac, is 18.
Airwallex Yield Service Goes Live In Hong Kong
Airwallex has officially launched Airwallex Yield in Hong Kong on 18 June 2025, which it advertises to offer businesses... Read more
Alipay And Rokid Launch AR Glasses Payment Function For In-Store Payments In China
Rokid has launched its latest augmented reality device, Rokid Glasses. In China, the Rokid AR payment glasses support i... Read more
InvestHKs Gulf Cooperation Council Fintech Visit Spurs Strategic Partnerships
Invest Hong Kong (InvestHK) reinforced its role as a global business hub through a strategic visit to the Gulf Cooperat... Read more
Can Crypto Firms Catch Up On Compliance Gaps As Regulations Evolve?
As crypto adoption accelerates, regulators are ramping up enforcement of the Financial Action Task Force’s (FATF) Tra... Read more
OneDegree Eyes Global Growth With Middle East, Europe And Africa Next
Hong Kong virtual insurer OneDegree has made significant progress in the Middle East, securing 20 contracts since enter... Read more
IFAST Introduces Bondsupermart Live With Stock-like Trading Experience For Bond Investors
To address structural inefficiencies in bond markets, iFAST introduced Bondsupermart Live, a digital bond trading servi... Read more